Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Calliditas Therapeutics AB ADR
CALT
$
29.3
6.6%
Sun November 15th, 2020
17:33
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
IPO
Analysis
Digest
Week In Review: RemeGen, A Yantai Biologics Company, Completes $515 Million Hong Kong IPO
Seeking Alpha
Mon November 9th, 2020
04:47
Press Releases
Calliditas Announces Positive Topline Results from Pivotal Phase 3 NefIgArd Trial
PR Newswire
Sun August 16th, 2020
08:10
Analysis
Mallinckrodt BLA Submission, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha
Sat June 6th, 2020
15:16
IPO
Analysis
Digest
U.S. IPO Weekly Recap: 8 IPOs Mark The Busiest Week Yet For The IPO Market
Seeking Alpha
Wed June 3rd, 2020
10:14
IPO
Analysis
This Is The IPO Market's Busiest Week Of The Year With 8 Deals On The Calendar
Seeking Alpha
